Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Pediatrics/Neonatology | Pulmonary/Respiratory Diseases | Family Medicine
Disease Category: Asthma (Pediatric)
Location: United States, FL
Clinical Trial Details
Research Study Summary
Does your child have asthma?
A 6-month safety and benefit study of inhaled fluticasone
propionate/ salmeterol combination versus inhaled fluticasone propionate in the treatment of 6,200 pediatric subjects 4-11 years old with persistent asthma. There is no placebo in this clinical research study. There will be no blood draws during this clinical research study. All study participants will receive asthma medication at no charge. Health insurance is not needed to participate. Compensation may be provided for time and travel. Patient Inclusion Description: Are 4 to 11 years of age, have had asthma for at least six months, have had asthma bad enough to see a doctor in the last 12 months.
Patient Exclusion Criteria:
- Subject has unstable asthma in the 7 days prior to Visit 1, Subject has a chronic pulmonary disease OTHER than bronchial asthma, Subject has an acute upper or lower respiratory tract infection at Visit 1, Subject required oral corticosteroids for asthma exacerbation WITHIN 4 weeks of Visit 1, Subject had GREATER than 4 episodes of asthma exacerbation requiring oral corticosteroids in the 12 months prior to Visit 1, Subject had GREATER than 2 hospitalizations for asthma exacerbation in the last 12 months prior to visit 1,
To Learn more
Both Male and Female
Date Last Changed:
July 18, 2013
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.